Key result
Peripartum cardiomyopathy carries ~24% five-year mortality despite frequent LVEF recovery.
Why the study?
The clinical course and 5-year prognosis of life in patients with peripartum cardiomyopathy needed to be studied.
Cohort (n=51)
In patients with peripartum cardiomyopathy, 5-year mortality remains high at 24%, with poor outcomes associated with severe baseline systolic dysfunction and LBBB.
High 5-year mortality in peripartum cardiomyopathy warrants ongoing surveillance; leaves open optimal interventions pending prospective trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Цой et al. (2022) conducted a cohort in Peripartum cardiomyopathy (n=51). Over a 5-year follow-up, peripartum cardiomyopathy resulted in left ventricular ejection fraction recovery in 43% of patients and an overall mortality rate of 24%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: